Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 72001-72050 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05813236
NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery
NARecruiting
84 participants
Started: Jun 28, 2023 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT06034912
Fundus Effects of Repeated Low-Level Red-Light Therapy in Chinese Myopic Minors: A Randomized Controlled Clinical Trial
NARecruiting
70 participants
Started: Jun 28, 2023 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT05155163
Stepped Care for Patients to Optimize Whole Recovery
NARecruiting
204 participants
Started: Jun 28, 2023 · Completed: Aug 31, 2026
2 conditions2 sponsors2 locations
NCT05856448
A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus
PHASE2Active, not recruiting
186 participants
Started: Jun 28, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor84 locations
NCT05810402
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
NARecruiting
60 participants
Started: Jun 28, 2023 · Completed: May 31, 2027
5 conditions1 sponsor1 location
NCT05783466
Dairy Lipids and Cardiometabolic Risk
NARecruiting
75 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2026
1 condition4 sponsors2 locations
NCT05766774
FEED-Cystic Fibrosis (FEED-CF)
NARecruiting
60 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2028
2 conditions2 sponsors1 location
NCT05785754
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
320 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor35 locations
NCT05913804
YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
12 participants
Started: Jun 28, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05934149
Lupus Landmark Study: A Prospective Registry and Biorepository
N/ARecruiting
3,500 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2035
3 conditions1 sponsor21 locations
NCT05671510
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
PHASE3Recruiting
600 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors160 locations
NCT06699446
"The Seamless Patient:From Preoperative Preparation to Postoperative Rehabilitation"
NARecruiting
300 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05878769
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
PHASE3Recruiting
2,000 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor462 locations
NCT06345820
Comparison of Two Non-diffractive Enhanced Monofocal Intraocular Lenses
NARecruiting
35 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05999448
Promoting the Well Being of Caregivers Via Telehealth
NARecruiting
800 participants
Started: Jun 28, 2023 · Completed: Dec 29, 2025
2 conditions7 sponsors1 location
NCT05396248
Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
NARecruiting
120 participants
Started: Jun 28, 2023 · Completed: Mar 31, 2027
1 condition3 sponsors2 locations
NCT05672550
Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)
PHASE4Recruiting
50 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor18 locations
NCT05661643
The Efficacy and Safety of Temozolomide in SDH-deficient GIST
PHASE2Recruiting
29 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05701241
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
PHASE4Recruiting
270 participants
Started: Jun 28, 2023 · Completed: Apr 30, 2034
1 condition4 sponsors19 locations
NCT05783687
Real World Evidence Study in Subjects With Wilson's Disease
N/AActive, not recruiting
50 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations
NCT06516445
SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
PHASE2Recruiting
33 participants
Started: Jun 28, 2023 · Completed: Jun 28, 2026
1 condition1 sponsor1 location
NCT05725096
Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population
NARecruiting
3,400 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
4 conditions1 sponsor1 location
NCT06016946
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
N/ARecruiting
3,000 participants
Started: Jun 28, 2023 · Completed: Jan 28, 2048
1 condition1 sponsor34 locations
NCT06018636
Impact of Diet and Nutrition on Growth and Development in Young Children
N/ARecruiting
832 participants
Started: Jun 28, 2023 · Completed: Sep 30, 2028
7 conditions4 sponsors1 location
NCT06028555
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
N/ARecruiting
101,000 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2028
2 conditions3 sponsors1 location
NCT05945433
Anovo™ Surgical System - Registry Study
N/ARecruiting
300 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05806099
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
PHASE1/PHASE2Recruiting
132 participants
Started: Jun 28, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05753137
Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
NARecruiting
50 participants
Started: Jun 28, 2023 · Completed: Jun 27, 2025
3 conditions1 sponsor1 location
NCT05768776
Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology
N/AActive, not recruiting
200 participants
Started: Jun 28, 2023 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05954780
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma
N/ARecruiting
100 participants
Started: Jun 28, 2023 · Completed: Oct 30, 2026
1 condition3 sponsors2 locations
NCT05853965
Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory T(11;14) Multiple Myeloma
PHASE1/PHASE2Recruiting
45 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor5 locations
NCT06523647
Clinical Efficacy of Ustekinumab in Crohn's Disease
N/ARecruiting
150 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT06178185
A Novel Study Evaluating Patients Awaiting Total Hip Arthroplasty (PRIORITEES)
N/ARecruiting
240 participants
Started: Jun 27, 2023 · Completed: Jun 27, 2024
1 condition1 sponsor1 location
NCT06018220
Percutaneous Dilatational Tracheostomy vs. Surgical Tracheostomy in Neurocritically Ill Patients - a Retrospective Study
N/ARecruiting
383 participants
Started: Jun 27, 2023 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05817318
Renal Denervation in Patients With Recurrent Atrial Fibrillation After Successful Pulmonary Vein Isolation
NARecruiting
40 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT05885607
Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
N/AEnrolling by invitation
40 participants
Started: Jun 27, 2023 · Completed: Mar 31, 2026
3 conditions2 sponsors1 location
NCT06469632
Radiofrequency and Myofascial Pain Syndrome in Postpartum Pelvic Pain
NARecruiting
74 participants
Started: Jun 27, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05838768
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
PHASE1Recruiting
327 participants
Started: Jun 27, 2023 · Completed: May 30, 2029
1 condition1 sponsor30 locations
NCT05879978
A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
PHASE1/PHASE2Active, not recruiting
45 participants
Started: Jun 27, 2023 · Completed: Dec 26, 2025
2 conditions1 sponsor8 locations
NCT05848050
Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases
NARecruiting
30 participants
Started: Jun 27, 2023 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT06182098
Intravenous Fluids in Pediatric Migraine
NARecruiting
134 participants
Started: Jun 27, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT05935904
Progression of Metabolic Syndrome Components During Pregnancy
N/ARecruiting
526 participants
Started: Jun 27, 2023 · Completed: Dec 30, 2024
5 conditions3 sponsors1 location
NCT06052436
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
PHASE1/PHASE2Recruiting
24 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05732701
Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NARecruiting
2,788 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2028
3 conditions1 sponsor3 locations
NCT05389423
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
PHASE1Recruiting
25 participants
Started: Jun 27, 2023 · Completed: Jun 1, 2032
5 conditions1 sponsor1 location
NCT05227612
Psilocybin-assisted CBT for Depression
EARLY_PHASE1Recruiting
62 participants
Started: Jun 27, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05708352
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
PHASE2Recruiting
170 participants
Started: Jun 27, 2023 · Completed: Sep 30, 2029
1 condition2 sponsors5 locations
NCT05933694
Spirometry Interpretation Performance of Primary Care Clinicians With/Without AI Software
NARecruiting
228 participants
Started: Jun 27, 2023 · Completed: Sep 30, 2024
1 condition2 sponsors1 location
NCT05799521
A Nasal Treatment for COVID-19
PHASE2Recruiting
40 participants
Started: Jun 27, 2023 · Completed: Mar 30, 2026
1 condition1 sponsor1 location
NCT05919940
Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )
NARecruiting
40 participants
Started: Jun 27, 2023 · Completed: Jan 31, 2026
6 conditions6 sponsors4 locations